HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Eisemann, C. Articles by Gissmann, L. Search for Related Content PubMed PubMed Citation Articles by Eisemann, C. Articles by Gissmann, L. Agricola Articles by Eisemann, C. Articles by Gissmann, L.

Antibodies to human papillomavirus type 11 virus-like particles in sera of patients with genital warts and in control groups

¹ Deutsches Krebsforschungszentrum, Forschungsschwerpunkt Angewandte Tumorvirologie, Heidelberg, Germany
² Department of Obstetrics and Gynecology, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA
³ Universitätskrankenhaus Eppendorf, Hautklinik, Hamburg, Germany

We analysed by ELISA a total of 478 human sera for the presence of antibodies to HPV-11 virus-like particles. The sera were obtained from patients with current genital warts (group CO), from males attending the hospital for fertility disorders (group MA), from blood donors (group BD) and from patients hospitalized for reasons unrelated to HPV infections (group HO). Antibody prevalence was higher in male patients of group CO (23.0%) as compared to males of groups MA (3.2%; P < 0.0001), HO (5.3%; P = 0.01) and BD (16.7%; NS). In addition, there was a significant difference in antibody titre between the males of group CO compared to group MA. Within the whole sample the absorbance of sera from females was higher than in specimens from males (P < 0.0001). A small subset of the sera was also tested by radioimmunoprecipitation assay (RIPA). There was good agreement between the data obtained by ELISA and RIPA.

Received 11 November 1995; accepted 1 March 1996.

This article has been cited by other articles:

				Y. Sun, J. Eluf-Neto, F. X. Bosch, N. Muñoz, J. M. M. Walboomers, C. J. L. M. Meijer, K. V. Shah, B. Clayman, and R. P. Viscidi Serum Antibodies to Human Papillomavirus 16 Proteins in Women from Brazil with Invasive Cervical Carcinoma Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 935 - 940. [Abstract] [Full Text]